Oxoid, a microbiology brand, is supplying Brilliance MRSA Agar to hospital laboratories worldwide, as an ideal solution to the problem of MRSA screening.
Oxoid, a world leading microbiology brand, is supplying BrillianceTM MRSA Agar to hospital laboratories worldwide, as an ideal solution to the problem of MRSA screening.
Oxoid Brilliance MRSA Agar is a selective chromogenic medium that permits primary growth, selectivity and differentiation of MRSA colonies on a single plate (see photograph). Brilliance MRSA Agar is both fast and reliable and, unlike other rapid methods such as PCR, it requires no capital outlay and is accessible to every hospital laboratory.
Brilliance MRSA Agar is already being used by many microbiology laboratories, including all three sites in the year-long pilot screening programme currently running in Scotland; NHS Ayrshire & Arran, NHS Grampian and NHS Western Isles. Trials began in April 2008 and are backed by £7 million of government investment in 2008-09.
Speak to your local Oxoid representative for more details. Alternatively, visit www.oxoid.com to download the product datasheet and other reference materials, or contact Val Kane, tel +44 (0)1256 841144, fax +44 (0)1256 329728, email [email protected]
Oxoid is part of Thermo Fisher Scientific Inc., the world leader in serving science.
